JP Morgan Chase
CAMP icon

JP Morgan Chase’s CAMP4 Therapeutics CAMP Stock Holding History

JP Morgan Chase’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.2K Buy
+13,116
New +$56.5K ﹤0.01% 6366
2025
Q3 		– Sell
-238
Closed -$345 – 7416
2025
Q2 		$345 Sell
238
-8,005
-97% -$15.9K ﹤0.01% 6735
2025
Q1 		$33K Sell
8,243
-13,029
-61% -$63K ﹤0.01% 6010
2024
Q4 		$111K Buy
+21,272
New +$175K ﹤0.01% 5716

Other funds holding CAMP

JT
Jupiter Topco New York $245B AUM
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase's CAMP Position: Q2 2026 in Review

JP Morgan Chase opened a new position in CAMP4 Therapeutics (CAMP) in Q2 2026: 13,116 shares worth $58.2K. The stake represents ﹤0.01% of the portfolio and ranks #6366 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in CAMP as recently as Q2 2025.

JP Morgan Chase first reported a position in CAMP in Q4 2024 and has held it in 4 quarters since. The position peaked at $111K in Q4 2024. 61 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

  • JP Morgan Chase held 13,116 shares of CAMP4 Therapeutics worth $58.2K as of Q2 2026.
  • CAMP4 Therapeutics was a new JP Morgan Chase position in Q2 2026.
  • CAMP4 Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6366 holding.
  • JP Morgan Chase first reported a position in CAMP4 Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • JP Morgan Chase's CAMP4 Therapeutics position peaked at $111K in Q4 2024.
  • 61 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.